H. Dohner, E. Estey, S. Amadori, F. Appelbaum, T. Buchner et al., Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet, Blood, vol.115, issue.3, pp.453-74, 2010.
DOI : 10.1182/blood-2009-07-235358

H. Liu, X. Zhai, Z. Song, J. Sun, Y. Xiao et al., Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study, Journal of Hematology & Oncology, vol.6, issue.1, p.15, 2013.
DOI : 10.1182/blood-2002-08-2398

D. Weisdorf, M. Eapen, A. Ruggeri, M. Zhang, X. Zhong et al., Alternative Donor Transplantation for Older Patients with Acute Myeloid Leukemia in First Complete Remission: A Center for International Blood and Marrow Transplant Research-Eurocord Analysis, Biology of Blood and Marrow Transplantation, vol.20, issue.6, pp.816-838, 2014.
DOI : 10.1016/j.bbmt.2014.02.020

A. Ruggeri, G. Sanz, H. Bittencourt, J. Sanz, A. Rambaldi et al., Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT, Leukemia, vol.100, issue.4, pp.779-86, 2014.
DOI : 10.1182/blood.V98.8.2332

J. Passweg, H. Baldomero, P. Bader, C. Bonini, S. Cesaro et al., Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants, Bone Marrow Transplantation, vol.8, issue.4, pp.476-82, 2015.
DOI : 10.1016/j.bbmt.2014.05.015

A. Ruggeri, M. Labopin, G. Sanz, S. Piemontese, W. Arcese et al., Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia, Leukemia, vol.90, issue.9, pp.1891-900, 2015.
DOI : 10.1182/blood-2008-02-140095

Y. Chang, X. Zhao, L. Xu, X. Zhang, Y. Wang et al., Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets, Journal of Hematology & Oncology, vol.8, issue.1, p.84, 2015.
DOI : 10.1016/j.bbmt.2005.09.004

T. Hahn, M. Jr, P. Hassebroek, A. Bredeson, C. Gajewski et al., Significant Improvement in Survival After Allogeneic Hematopoietic Cell Transplantation During a Period of Significantly Increased Use, Older Recipient Age, and Use of Unrelated Donors, Journal of Clinical Oncology, vol.31, issue.19, pp.2437-2486, 2013.
DOI : 10.1200/JCO.2012.46.6193

S. Randolph, T. Gooley, E. Warren, F. Appelbaum, and S. Riddell, Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants, Blood, vol.103, issue.1, pp.347-52, 2004.
DOI : 10.1182/blood-2003-07-2603

M. Schmidt-hieber, M. Labopin, D. Beelen, L. Volin, G. Ehninger et al., CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT, Blood, vol.122, issue.19, pp.3359-64, 2013.
DOI : 10.1182/blood-2013-05-499830

E. Goulmy, A. Termijtelen, B. Bradley, and J. Van-rood, Y-antigen killing by T cells of women is restricted by HLA, Nature, vol.4, issue.5602, pp.544-549, 1977.
DOI : 10.1038/262795a0

M. Bleakley and S. Riddell, Molecules and mechanisms of the graft-versus-leukaemia effect, Nature Reviews Cancer, vol.4, issue.5, pp.371-80, 2004.
DOI : 10.1038/nrc1365

E. Zorn, D. Miklos, B. Floyd, A. Mattes-ritz, L. Guo et al., Minor Histocompatibility Antigen DBY Elicits a Coordinated B and T Cell Response after Allogeneic Stem Cell Transplantation, The Journal of Experimental Medicine, vol.96, issue.8, pp.1133-1175, 2004.
DOI : 10.1191/096120398678920613

D. Miklos, H. Kim, K. Miller, L. Guo, E. Zorn et al., Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission, Blood, vol.105, issue.7, pp.2973-2981, 2005.
DOI : 10.1182/blood-2004-09-3660

R. Popli, B. Sahaf, H. Nakasone, J. Lee, and D. Miklos, Clinical impact of H-Y alloimmunity, Immunologic Research, vol.107, issue.20, pp.249-58, 2014.
DOI : 10.1007/s12026-014-8514-3

B. Blazar, W. Murphy, and M. Abedi, Advances in graft-versus-host disease biology and therapy, Nature Reviews Immunology, vol.69, issue.6, pp.443-58, 2012.
DOI : 10.1038/nri3212

G. Socie and J. Ritz, Current issues in chronic graft-versus-host disease, Blood, vol.124, issue.3, pp.374-84, 2014.
DOI : 10.1182/blood-2014-01-514752

K. Markey, K. Macdonald, and G. Hill, The biology of graft-versus-host disease: experimental systems instructing clinical practice, Blood, vol.124, issue.3, pp.354-62, 2014.
DOI : 10.1182/blood-2014-02-514745

M. Loschi, R. Porcher, P. De-latour, R. Vanneaux, V. et al., High Number of Memory T Cells Is Associated with Higher Risk of Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation, vol.21, issue.3, pp.569-74, 2014.
DOI : 10.1016/j.bbmt.2014.12.009

X. Zhang, B. Mozeleski, S. Lemoine, E. Deriaud, A. Lim et al., CD4 T Cells with Effector Memory Phenotype and Function Develop in the Sterile Environment of the Fetus, Science Translational Medicine, vol.6, issue.238, pp.238-272, 2014.
DOI : 10.1126/scitranslmed.3008748
URL : https://hal.archives-ouvertes.fr/hal-01060153

M. Eapen, J. Klein, A. Ruggeri, S. Spellman, S. Lee et al., Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy, Blood, vol.123, issue.1, pp.133-173, 2014.
DOI : 10.1182/blood-2013-05-506253

K. Page, A. Mendizabal, B. Betz-stablein, S. Wease, K. Shoulars et al., Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality, Transfusion, vol.52, pp.340-52, 2014.
DOI : 10.1111/trf.12257

N. Rufer, E. Wolpert, C. Helg, J. Tiercy, A. Gratwohl et al., HA-1 AND THE SMCY-DERIVED PEPTIDE FIDSYICQV (H-Y) ARE IMMUNODOMINANT MINOR HISTOCOMPATIBILITY ANTIGENS AFTER BONE MARROW TRANSPLANTATION1, Transplantation, vol.66, issue.7, pp.910-916, 1998.
DOI : 10.1097/00007890-199810150-00016

P. Weiden, K. Sullivan, N. Flournoy, R. Storb, and E. Thomas, Antileukemic Effect of Chronic Graft-versus-Host Disease, New England Journal of Medicine, vol.304, issue.25, pp.1529-1562, 1981.
DOI : 10.1056/NEJM198106183042507

F. Baron, M. Maris, B. Sandmaier, B. Storer, M. Sorror et al., Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation With Nonmyeloablative Conditioning, Journal of Clinical Oncology, vol.23, issue.9, pp.1993-2003, 2005.
DOI : 10.1200/JCO.2005.08.136

F. Baron, M. Labopin, D. Niederwieser, S. Vigouroux, J. Cornelissen et al., Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation, Leukemia, vol.11, issue.12, pp.2462-2470, 2012.
DOI : 10.1056/NEJMoa1108188

R. Storb, B. Gyurkocza, B. Storer, M. Sorror, K. Blume et al., Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation, Journal of Clinical Oncology, vol.31, issue.12, pp.1530-1538, 2013.
DOI : 10.1200/JCO.2012.45.0247

Y. Kim and H. Broxmeyer, Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance, Critical Reviews in Oncology/Hematology, vol.79, issue.2, pp.112-138, 2011.
DOI : 10.1016/j.critrevonc.2010.07.009

K. Ballen, E. Gluckman, and H. Broxmeyer, Umbilical cord blood transplantation: the first 25 years and beyond, Blood, vol.122, issue.4, pp.491-499, 2013.
DOI : 10.1182/blood-2013-02-453175

T. Konuma, S. Kato, J. Ooi, M. Oiwa-monna, Y. Ebihara et al., Impact of sex incompatibility on the outcome of single-unit cord blood transplantation for adult patients with hematological malignancies, Bone Marrow Transplantation, vol.75, issue.5, pp.634-643, 2014.
DOI : 10.1182/blood-2004-09-3660

F. Baron, P. Zachee, J. Maertens, T. Kerre, A. Ory et al., Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2??Gy TBI or ATG plus 8??Gy TLI: a phase II randomized study from the Belgian Hematological Society, Journal of Hematology & Oncology, vol.8, issue.1, p.4, 2015.
DOI : 10.1016/j.bbmt.2005.09.004

Y. Lai, Y. Chen, D. Hu, M. Jiang, Q. Liu et al., Multicenter phase ii study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG), Journal of Hematology & Oncology, vol.18, issue.11, p.59, 2014.
DOI : 10.1186/s13045-014-0059-3

M. Stern, L. De-wreede, R. Brand, A. Van-biezen, P. Dreger et al., Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis, Leukemia, vol.18, issue.11, pp.2235-2275, 2014.
DOI : 10.1002/ajh.23404

K. Sullivan, P. Weiden, R. Storb, R. Witherspoon, A. Fefer et al., Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia, Blood, vol.73, pp.1720-1728, 1989.

L. Pascal, M. Mohty, A. Ruggeri, L. Tucunduva, N. Milpied et al., Impact of rabbit ATG-containing myeloablative conditioning regimens on the outcome of patients undergoing unrelated single-unit cord blood transplantation for hematological malignancies, Bone Marrow Transplantation, vol.96, issue.1, pp.45-50, 2015.
DOI : 10.1016/S1083-8791(03)00127-7

M. Hannon, Y. Beguin, G. Ehx, S. Servais, L. Seidel et al., Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Following Flu-TBI versus TLI-ATG Conditioning, Clinical Cancer Research, vol.21, issue.14, pp.3131-3140, 2015.
DOI : 10.1158/1078-0432.CCR-14-3374

G. Socie, C. Schmoor, W. Bethge, H. Ottinger, M. Stelljes et al., Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius, Blood, vol.117, issue.23, pp.6375-82, 2011.
DOI : 10.1182/blood-2011-01-329821

F. Baron, M. Labopin, D. Blaise, L. Lopez-corral, S. Vigouroux et al., Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation, Bone Marrow Transplantation, vol.47, issue.3, pp.389-96, 2014.
DOI : 10.1038/bmt.2012.131

F. Bonifazi, C. Solano, C. Wolschke, F. Patriarca, M. Pini et al., Prevention of Chronic GvHD after HLA-Identical Sibling Peripheral Hematopoietic Stem Cell Transplantation with or without anti-lymphocyte globulin (ATG). Results from a Prospective, Multicenter Randomized Phase III Trial (ATG family study), Blood, vol.124, p.37, 2014.

L. Tucunduva, A. Ruggeri, G. Sanz, S. Furst, G. Socie et al., Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation, Bone Marrow Transplantation, vol.90, issue.7, pp.887-94, 2014.
DOI : 10.1182/blood-2012-06-379040

F. Michelis, E. Atenafu, V. Gupta, D. Kim, J. Kuruvilla et al., Comparable outcomes post allogeneic hematopoietic cell transplant for patients with de novo or secondary acute myeloid leukemia in first remission, Bone Marrow Transplantation, vol.115, issue.7, 2015.
DOI : 10.1038/bmt.2015.59

H. Glucksberg, R. Storb, A. Fefer, C. Buckner, P. Neiman et al., CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S, Transplantation, vol.18, issue.4, pp.295-304, 1974.
DOI : 10.1097/00007890-197410000-00001